Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_assertion type Assertion NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_head.
- NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_assertion description "[ChoK? specific inhibitors, MN58b and TCD-717, have demonstrated a potent antitumoral activity both in vitro and in vivo against several tumor-derived cell line xenografts including CRC-derived cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_provenance.
- NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_assertion evidence source_evidence_literature NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_provenance.
- NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_assertion SIO_000772 23762272 NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_provenance.
- NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_assertion wasDerivedFrom befree-20150227 NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_provenance.
- NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_assertion wasGeneratedBy ECO_0000203 NP313816.RArcF5OXKsW5A58ejyEmQE5yF1pmdxbfm0jwbCdwqtPmk130_provenance.